Transmedics Group Stock Probability of Future Stock Price Finishing Under 52.35

TMDX Stock  USD 63.90  1.25  2.00%   
TransMedics' future price is the expected price of TransMedics instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of TransMedics Group performance during a given time horizon utilizing its historical volatility. Check out TransMedics Backtesting, TransMedics Valuation, TransMedics Correlation, TransMedics Hype Analysis, TransMedics Volatility, TransMedics History as well as TransMedics Performance.
  
At this time, TransMedics' Price Book Value Ratio is fairly stable compared to the past year. Price Earnings To Growth Ratio is likely to rise to 2.88 in 2024, whereas Price To Sales Ratio is likely to drop 10.09 in 2024. Please specify TransMedics' target price for which you would like TransMedics odds to be computed.

TransMedics Target Price Odds to finish below 52.35

The tendency of TransMedics Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to drop to $ 52.35  or more in 90 days
 63.90 90 days 52.35 
about 6.31
Based on a normal probability distribution, the odds of TransMedics to drop to $ 52.35  or more in 90 days from now is about 6.31 (This TransMedics Group probability density function shows the probability of TransMedics Stock to fall within a particular range of prices over 90 days) . Probability of TransMedics Group price to stay between $ 52.35  and its current price of $63.9 at the end of the 90-day period is about 5.94 .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.78 . This usually implies as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, TransMedics will likely underperform. Additionally TransMedics Group has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   TransMedics Price Density   
       Price  

Predictive Modules for TransMedics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as TransMedics Group. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of TransMedics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
60.0065.4870.96
Details
Intrinsic
Valuation
LowRealHigh
57.5174.5580.03
Details
9 Analysts
Consensus
LowTargetHigh
79.8587.7597.40
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.210.220.26
Details

TransMedics Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. TransMedics is not an exception. The market had few large corrections towards the TransMedics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold TransMedics Group, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of TransMedics within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-1.29
β
Beta against Dow Jones1.78
σ
Overall volatility
31.57
Ir
Information ratio -0.23

TransMedics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of TransMedics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for TransMedics Group can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
TransMedics Group generated a negative expected return over the last 90 days
TransMedics Group has high historical volatility and very poor performance
The company reported the previous year's revenue of 241.62 M. Net Loss for the year was (25.03 M) with profit before overhead, payroll, taxes, and interest of 65.27 M.
TransMedics Group currently holds about 204.46 M in cash with (13.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.41.
TransMedics Group has a frail financial position based on the latest SEC disclosures
Over 97.0% of the company shares are owned by institutional investors
Latest headline from gurufocus.com: TransMedics Group Inc to Present at J.P. Morgan Healthcare Conference

TransMedics Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of TransMedics Stock often depends not only on the future outlook of the current and potential TransMedics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. TransMedics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding32.5 M
Cash And Short Term Investments394.8 M

TransMedics Technical Analysis

TransMedics' future price can be derived by breaking down and analyzing its technical indicators over time. TransMedics Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of TransMedics Group. In general, you should focus on analyzing TransMedics Stock price patterns and their correlations with different microeconomic environments and drivers.

TransMedics Predictive Forecast Models

TransMedics' time-series forecasting models is one of many TransMedics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary TransMedics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about TransMedics Group

Checking the ongoing alerts about TransMedics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for TransMedics Group help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
TransMedics Group generated a negative expected return over the last 90 days
TransMedics Group has high historical volatility and very poor performance
The company reported the previous year's revenue of 241.62 M. Net Loss for the year was (25.03 M) with profit before overhead, payroll, taxes, and interest of 65.27 M.
TransMedics Group currently holds about 204.46 M in cash with (13.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.41.
TransMedics Group has a frail financial position based on the latest SEC disclosures
Over 97.0% of the company shares are owned by institutional investors
Latest headline from gurufocus.com: TransMedics Group Inc to Present at J.P. Morgan Healthcare Conference

Additional Tools for TransMedics Stock Analysis

When running TransMedics' price analysis, check to measure TransMedics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TransMedics is operating at the current time. Most of TransMedics' value examination focuses on studying past and present price action to predict the probability of TransMedics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TransMedics' price. Additionally, you may evaluate how the addition of TransMedics to your portfolios can decrease your overall portfolio volatility.